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Chlamydophila pneumoniae is a common cause of
respiratory infections. Infection with this obliga-
tory intracellular pathogen may remain chronic
in some individuals, and may be associated with
several serious disorders such as asthma, chronic
obstructive pulmonary disease and ischemic heart
disease.1–3 Hahn and colleagues were the first 
to report an association between infection with 
C. pneumoniae and the development of asthma.4
Since then, increasing evidence has suggested that
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Background/Purpose: Chlamydophila pneumoniae infection has been associated with several pulmonary
and cardiac diseases. However, it has not been explored for its ability to activate the same immunopatho-
logic mechanisms of asthma, namely, a predominant Th2 immune response and structural changes that
are termed airway remodeling. This study evaluated immune responses in the lung and airway pathology
of BALB/c mice with chronic and repeated C. pneumoniae infections.
Methods: Mice were inoculated intranasally with 5 × 106 inclusion-forming units of C. pneumoniae TWAR
strain, and re-inoculated at 14 and 42 days after the primary inoculation. Cytokine gene expression in
bronchoalveolar lavage (BAL) cells was analyzed by RT-PCR on day 70. Airway pathology was also evaluated
by morphometric measurements.
Results: A significant increase of interleukin (IL)-4 mRNA was detected in BAL cells in infected mice, and
a significant increase in subepithelial basement membrane thickness of the airways was also noted in 
infected mice as compared with control mice (8.95 ± 0.28 μm vs. 5.54 ± 0.22 μm, p < 0.0001). We further
analyzed the correlation between IL-4 cytokine expression and the increased subepithelial basement
membrane thickness of airways in infected mice. We found that mice with increased IL-4 mRNA expres-
sion had significant increases in the thickness of subepithelial basement membrane as compared with
mice without increased IL-4 mRNA expression (9.87 ± 0.51 μm vs. 6.49 ± 0.52 μm, p < 0.0001).
Conclusion: It is believed that our results demonstrated for the first time that chronic and repeated infec-
tions with C. pneumoniae increased IL-4 gene expression and thickness of airway subepithelial basement
membrane in mice. [J Formos Med Assoc 2009;108(1):45–52]
Key Words: airway remodeling, Chlamydophila pneumoniae, interleukin-4
ORIGINAL ARTICLE
©2009 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Department of Internal Medicine, National Cheng Kung University Hospital, 2Department of Microbiology and
Immunology, and 3Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University
Medical College, Tainan, Taiwan.
Received: March 10, 2008
Revised: April 30, 2008
Accepted: June 4, 2008
*Correspondence to: Dr Tzuen-Ren Hsiue, Department of Internal Medicine, National
Cheng Kung University Hospital, 138 Sheng-Li Road, Tainan 704, Taiwan.
E-mail: hsiue@mail.ncku.edu.tw
persistent lung infection caused by C. pneumoniae
is associated with the initiation, exacerbation and
promotion of asthma.5–7 However, a causal rela-
tionship between C. pneumoniae infection and
asthma remains to be established.
Asthma is a chronic inflammatory disease of
the lung, characterized by airway hyperresponsive-
ness (AHR), and structural changes in the airway
walls. Such airway remodeling includes thicken-
ing of the subepithelial basement membrane, gob-
let cell hyperplasia with mucus hypersecretion,
enlargement of the bronchial smooth muscle mass
and growth of new vessels. Currently available data
suggest that an important mechanism for AHR
and airway remodeling in asthma is the action of
Th2 cytokines.8–11 However, repeated infection
with C. pneumoniae elicits interferon-γ (IFN-γ) pro-
duction in mice, which plays an important role in
the clearance and pathogenesis of C. pneumoniae.12
In addition to IFN-γ, previous studies have re-
ported that C. pneumoniae-infected monocytes pro-
duce interleukin (IL)-10,13 which is a powerful
inhibitor of IFN-γ and an important immuno-
suppressive regulator of cell-mediated immunity
and T-cell differentiation.14 In addition to IL-10,
Burian et al reported that IL-4 has a role in host
defense during acute C. pneumoniae infection.15
A Th2-predominant immune response would be
expected if there is an association between chronic
infection with C. pneumoniae and asthma, but 
a role for Th2 immune responses in chronic 
C. pneumoniae infection has not been established.
IL-4, IL-5 and IL-13 are important Th2 cytokines
that play a central role in bronchial asthma.16–18
In the present study, we analyzed immune re-
sponses, including gene expression of IFN-γ, IL-
4, IL-5 and IL-13, and the associated airway
remodeling in mice with chronic and persistent
C. pneumoniae infection. Our results demonstrated
that chronic and repeated C. pneumoniae lung infec-
tion increased IL-4 gene expression. Moreover, the
increased expression of IL-4 mRNA correlated pos-
itively with the increased thickness of subepithelial
basement membrane of airways in infected mice.
These results revealed that chronic and repeated
lung infections with C. pneumoniae induced Th2
cytokine expression and airway remodeling similar
to the inflammatory responses in human asthma.
Methods
Mice
Specific pathogen-free, 6–8-week-old male BALB/c
mice were obtained from the Laboratory Animal
Center, National Cheng Kung University, Taiwan.
The mice were housed in a micro-isolated cage and
provided with sterile food and water ad libitum.
All procedures were approved by the Animal Re-
search Ethics Board at National Cheng Kung
University.
C. pneumoniae strain and inoculum
preparation
TWAR ATCC strain AR 183 was used for inocula-
tion of mice. The organism was grown in HL
cells and purified by density gradient centrifuga-
tion using diatrizoate meglumine (Hypaque-76;
Winthrop-Breon Laboratories, New York, NY, USA).
The inoculum preparation was resuspended in
sucrose phosphate glutamic acid (SPG) medium
to provide a final inoculum of 1 × 107 inclusion-
forming units (IFU)/mL. These preparations were
frozen at –70°C until use.
Inoculation of mice
Mice were sedated by subcutaneous injection of a
mixture of ketamine and xylazine, and were inoc-
ulated intranasally with 5 × 106 IFU C. pneumoniae
suspended in 0.5 mL SPG medium. Mice were re-
inoculated at 14 days and 42 days after the pri-
mary inoculation. Control mice received 0.5 mL
sterile SPG medium, during primary inoculation
and re-inoculation. A total of 24 mice (experi-
mental mice) received intranasal inoculation of
C. pneumoniae suspension, and six control mice
received inoculation of SPG medium.
Bronchoalveolar lavage (BAL)
BAL was obtained at 70 days after primary inocula-
tion. Two separate doses of 1 mL sterile endotoxin-
free saline were injected into the lung via the
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trachea of each mouse. Approximately 1.8 mL
washing solution was recovered consistently. The
recovered BAL fluid volume was measured and
placed immediately on ice. Cells were sedimented
by centrifugation at 200g for 10 minutes at 4°C.
The supernatants were stored at –70°C until assay.
Histologic examination of lung
Mice were killed by an overdose of pentobarbital
and the whole lung and trachea were removed, and
the left lung was resected for culture of C. pneu-
moniae immediately at day 70. Two milliliters of
formalin fixative was instilled intratracheally until
the surface of the right lung was smooth. After fix-
ation for 2 days, four paraffin-embedded 5-mm
thick sections of the right lung were stained with
hematoxylin and eosin (H&E), and then exam-
ined by microscopy.
Morphometry measurements
The thickness of the subepithelial basement mem-
brane layer of the airways was evaluated by meas-
uring the basement membrane thickness beneath
the bronchial epithelium with H&E stain. We ap-
plied design-based stereology to biopsy analysis of
the thickness beneath the bronchial epithelium
by using an integrated system that includes a micro-
scope, automated microscope stage, video camera,
and computer equipped with stereology software.
Images of the airways under a microscope at 10×
and 20× magnification were captured in the com-
puter by an investigator who was blind to the tis-
sue codes for the study specimen. The thickness of
the subepithelial basement membrane at four dif-
ferent quadrants for each airway cross section was
examined, and the mean of these four measure-
ments was calculated. At least 14 airways were ex-
amined in each mouse, and the mean number of
airways examined was 18 (range, 14–25). All fields
of lung tissue were evaluated for morphometric
analysis.
Isolation of C. pneumoniae in lung tissue
Left lung tissues were homogenized and tested
for the presence of viable C. pneumoniae by inoc-
ulation in HL cells. Cells were grown in a 24-well
cell culture plate. Each sample was inoculated
into three wells and centrifuged at 1500 rpm for
60 minutes and subsequently incubated with
fresh medium that contained 0.6 mg/L cyclo-
heximide. After 3 days, one of the three wells 
was fixed with methanol and stained by FITC-
conjugated TT401. The other two wells were har-
vested and passed to HL cells. The specimens
were regarded as negative if inclusions were not
detected within three passages. In each culture
series, C. pneumoniae was included in parallel as
a positive control.
Semiquantitative RT-PCR
BAL cells were collected and after washing twice
in ice-cold PBS, the cell number was adjusted to
106/mL. Total cellular RNA was extracted by the
RNeasy total RNA kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions.
Total RNA was converted to cDNA with Strata
Script H-reverse transcriptase (Stratagene, La Jolla,
CA, USA) and oligo dT as a primer. The gener-
ated cDNA was subjected to 35 cycles of PCR
amplification by a DNA Thermal Cycler (Hybrid
Omnigene, UK). Gene-specific primer pairs (sense
and antisense, respectively) were as follows: IL-4:
5-ATGGGTCTCAACCCCCAGCTAGT-3 and 5-
GCTCTTTAGGCTTTCCAGGAAGTC-3; IL-5: 5-
GCACAGTGGTGAAAGAGACC-3 and 5-TTAACT-
GACTACAGGACATAAATA-3; IL-13: 5-AGACCA-
GACTCCCCTGTGCA-3 and 5-TGCACAGGGGAG-
TCTGGTCT-3; IFN-γ: 5-TGAACGCTACACACTG-
CATCTTGG-3 and 5-CGACTCCTTTTCCGCTTC-
CTGAG-3; and β-actin: 5-TGGAATCCTGTGG-
CATCCATGAAAC-3 and 5-TAAAACGCAGCTC-
AGTAACAGTCCG-3. For PCR amplification, a
100-μL reaction contained 1–3 μL cDNA mixture,
100 pmol for each primer, 2 mM of each dNTP,
1.5 nM of MgCl2, and 2.5 U of Taq DNA poly-
merase. Thirty-five amplification cycles were per-
formed, consisting of denaturation, 94°C for 30
seconds; annealing, 60°C for 45 seconds; and
extension, 72°C for 1 minute. PCR products were
fractionated by agarose gel electrophoresis, stained
with ethidium bromide, and visualized under 
ultraviolet light.
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Statistical analysis
Results were expressed as mean ± standard error
of the mean for the measurements of thickness
of subepithelial basement membrane. Differences
between infected and control groups were analyzed
by Student’s two-tailed t test. Multiple groups were
analyzed by ANOVA test. Differences were defined
as significant if p was < 0.05.
Results
Models of chronic and repeated 
C. pneumoniae lung infections in mice
Four C. pneumoniae-inoculated mice died before
day 70, and only 20 infected and six control mice
underwent the further experiments and were an-
alyzed. On day 70 after primary inoculation, a
chronic type of inflammation with perivascular
and peribronchial lymphocyte infiltration in the
lung was observed in all C. pneumoniae-inoculated
mice (Figure 1). Isolation of C. pneumoniae from
lung tissues was positive in all of the 20
C. pneumoniae-inoculated mice, and all infected
mice had a positive PCR test for C. pneumoniae
DNA (Table 1). No isolation of C. pneumoniae and
negative PCR test for C. pneumoniae DNA were
found for all six control mice.
Chronic and repeated C. pneumoniae lung
infections result in increasing gene 
expression of IL-4
We used RT-PCR to measure the gene expression
of IL-4, IL-5, IL-13 and IFN-γ in BAL fluid cells.
Repeated inoculations with C. pneumoniae re-
sulted in increased gene expression of IL-4
(Figure 2). Twelve of 20 (60%) infected mice had
increased expression of IL-4 mRNA in BAL cells.
No IL-4 mRNA expression was detected in con-
trol mice. In contrast to IL-4, the level of IL-13
and IFN-γ mRNA in BAL fluid cells did not differ
between the two groups (Table 2). No IL-5
mRNA expression was detected in infected or
control mice.
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Figure 1. Histologic examination of lungs (hematoxylin & eosin). (A) Diffuse perivascular and peribronchial lymphoid 
reaction with accumulation of foci of lymphocytes in the lung tissue of C. pneumoniae-infected mice (arrow). Also shows
increased thickness of subepithelial basement membrane layer in the airways of C. pneumoniae-infected mice. 
(B) Almost complete absence of pathologic change in the lung tissue of control mice. Bar = 50 μm.
Table 1. Isolation of C. pneumoniae in lung tissue and PCR test for C. pneumoniae in bronchoalveolar lavage
fluid in infected and control mice
Ratio of positive isolation of Ratio of positive PCR test for
C. pneumoniae in lung tissue C. pneumoniae in BAL fluid
C. pneumoniae inoculated mice 20/20 (100%) 20/20 (100%)
Control mice 0/6 (0%) 0/6 (0%)
Chronic and repeated C. pneumoniae lung
infections result in increased thickness of
subepithelial basement membrane
In order to determine if chronic and repeated 
C. pneumoniae lung infection resulted in increased
thickness of the subepithelial basement mem-
brane layer of the airways, morphometric analysis
was carried out. There was a significant increase
in the thickness of the basement membrane lay-
er, present in the airways of infected mice after
chronic and repeated C. pneumoniae lung infec-
tions (Figure 1). The thickness of the subepithelial
basement membrane layer of the airways in-
creased 1.6-fold in the infected as compared with
control mice (8.95 ± 0.28 μm vs. 5.54 ± 022 μm,
p < 0.0001) (Figure 3A). Mice with increasing IL-4
mRNA expression showed a positive correlation
with the increased thickness of subepithelial
basement membrane in infected mice. The thick-
ness of the subepithelial basement membrane 
in infected mice with increasing IL-4 mRNA 
and no IL-4 mRNA was 9.87 ± 0.51 μm and 6.49 ±
0.52 μm, respectively (p < 0.0001) (Figure 3B).
Neither increasing IFN-γ mRNA nor IL-13 mRNA
revealed a correlation with the thickness of the
subepithelial basement membrane in infected
mice.
Discussion
The cause of intrinsic asthma is not clear, and per-
sistent C. pneumoniae lung infection is speculated
to be associated with initiation or exacerbation
of adult intrinsic asthma. In this study, we devel-
oped a mouse model of chronic and repeated 
C. pneumoniae lung infection, and their patho-
logic changes with perivascular and peribronchial
lymphocyte infiltration, which were similar to
those of previous studies of chronic C. Pneumoniae
infection.19–22 We demonstrated that chronic and
repeated C. pneumoniae lung infection in mice in-
creased IL-4 mRNA expression, and this was cor-
related positively with the increased thickness of
the basement membrane of the airways. These
findings had some similarities with the increased
IL-4 gene expression and airway remodeling in
clinical asthma.
Increased production of IFN-γ and IL-4 have
been observed in a mouse model of acute 
C. pneumoniae lung infection15 and prolonged
ovalbumin challenge in sensitized mice.23 Halme
et al also reported interesting preliminary findings
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Table 2. RT-PCR analysis of cytokine gene expression in bronchoalveolar lavage cells in infected and control mice
Mice with C. pneumoniae Control mice
infection (n = 20) (n = 6)
Ratio of IL-4 mRNA expression 12/20 (60%*) 0/6 (0%)
Ratio of IL-13 mRNA expression 10/20 (50%) 4/6 (66%)
Ratio of IFN-γ mRNA expression 10/20 (50%) 4/6 (66%)
Ratio of IL-5 mRNA expression 0/20 (0%) 0/6 (0%)
*p < 0.01 vs. control mice.
IL-4
a
IFN-γ
β-actin
b c d e
Figure 2. Representative gel shows increased expression
of IL-4 mRNA in bronchoalveolar lavage cells in the first four
samples (a–d) detected by RT-PCR. The first four samples
were collected from infected mice and the last sample 
(e) was from control mice. No IL-4 mRNA expression was
noted in control mice.
that demonstrate IFN-γ and IL-4 mRNA expres-
sion in four human T-cell clones stimulated by
C. pneumoniae antigens.24 In our study, chronic
and repeated C. pneumoniae lung infection was
associated with increased IL-4 mRNA expression
in BAL cells of mice. IL-4 level in BAL cells was
also examined by ELISA in our study; however,
an undetectable concentration was noted in infec-
tion and control groups.
McMillan and Lloyd developed a model of pro-
longed allergen challenge that shares many char-
acteristics with the airway remodeling observed
in human chronic asthma; increased goblet cell
hyperplasia and collagen deposition during the
chronic phase were observed.23 In addition, up-
regulation of IL-4 was noted in their study, which
was similar to our study. We have developed a
model of chronic and repeated C. pneumonia lung
infection, in which coexistent Th1 (IFN-γ) and Th2
(IL-4) responses were detected. IL-4 was found 
to be dominant in the BAL fluid cells during 
the chronic phase, and the increased expression
of IL-4 mRNA correlated positively with the in-
creased thickness of the subepithelial basement
membrane. IL-4 has been described by several 
investigators to be a fibrogenic cytokine and has
been shown to regulate collagen biosynthesis in
fibroblasts.10,11 The increased thickness of the
subepithelial basement membrane in response
to IL-4 is an important characteristic of airway 
remodeling in asthma.
We found increased expression of IL-4 mRNA
in the mouse lung following repeated C. pneumonia
infection, but this result was different from pre-
vious studies. Penttila et al reported that a Th1-
type immune response with IFN-γ production is
characteristic of repeated infections, and have sug-
gested that it plays a major role in the pathogen-
esis of C. pneumoniae infection.12 In contrast, IL-4
immune responses were detected in our study, but
no IL-4 production was detected in their study.
The discrepancy between our findings and those
of Penttila et al may have several explanations.
First, the type of host cells analyzed may affect
the results. C. pneumoniae has been shown to be
able to grow and multiply in several cell types, in-
cluding mucosal epithelial cells, alveolar mac-
rophages, smooth muscle cells, and endothelial
cells.25–27 In our study, the cell profile in BAL fluid
in the initial six infected mice was: lymphocytes,
83.5%; eosinophils, 9.6%; neutrophils, 5.6%; and
macrophages, 1.3%. The study of Penttila et al
C.Z. Chen, et al
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Figure 3. Morphometric analysis of thickness of subepithelial basement membrane of airway. (A) Thickness of the
subepithelial basement membrane of airways was significantly increased in infected mice (n = 20) in comparison with
control mice (n=6). The thickness of the subepithelial basement membrane of airways increased 1.6-fold in the infected mice
compared with control mice (8.95 ± 0.28 μm vs. 5.54 ± 0.22 μm, p < 0.0001). (B) Thickness of subepithelial basement
membrane of airways was significantly increased in infected mice with increases of IL-4 mRNA expression (n=12), in com-
parison with infected mice without IL-4 mRNA expression (n = 8). The thickness of subepithelial basement membrane in
infected mice with and without increased IL-4 mRNA was 9.87 ± 0.51 μm and 6.49 ± 0.52 μm, respectively (p < 0.0001).
used purified mononuclear cells, which may have
resulted in the loss of some important cytokine-
modulating factors that are directly or indirectly
contributed by other cells. A second possible ex-
planation for the discrepancy is the difference in
the methods used to analyze cytokine presenta-
tion. We measured the gene expression of BAL
cells by RT-PCR, while Penttila et al used ELISA
for cytokine production. ELISA may not be suffi-
ciently sensitive to detect the small amount of cy-
tokines present in pulmonary mononuclear cells.
A third possible reason for the discrepancy is the
differences in the infected doses. In our model,
higher bacterial inocula were administered (5×106
IFU in our study vs. 1 × 106 IFU in Penttila et al’s
study). Cytokine response in C. pneumoniae infec-
tion has been shown to depend on the concen-
tration of the bacterial inoculum, and inoculation
of a higher concentration of bacteria increases
the release of cytokines.25 Th2-type immune re-
sponse with cytokine production may have been
too weak to be detected using the concentration
of bacteria used by Penttila et al. A high concen-
tration of bacteria also causes more severe inflam-
mation and target organ damage.28 In tuberculosis,
the severity of lung damage determines a predom-
inant Th1- or Th2-type response for milder or
progressive disease, respectively.29 Whether a sim-
ilar immunologic shift occurs in repeated in-
fections of C. pneumoniae should be considered. 
A fourth possible explanation for the discrepancy
was the use of a different C. pneumoniae strain,
which may have initiated different reactions.
Penttila et al used C. pneumoniae isolate Kajaani
6, while C. pneumoniae TWAR 183 was used in this
study. Studies of population antibody prevalence
have shown that > 50% of adults worldwide have
antibody against strain TWAR. It is important to
clarify the effects of differences between strains
when studying the immunopathologic mecha-
nisms of C. pneumoniae infection.
IL-13 plays an important role in the pathologic
changes of asthma.17 In our study, IL-13 mRNA
expression in BAL cells was not increased in com-
parison with controls. In the study of McMillan
and Lloyd, prolonged allergen challenge in mice
caused pathologic changes similar to the airway
remodeling in asthma. Levels of IL-13 in BAL re-
duced during the chronic phase, while IL-4 and
IFN-γ levels significantly increased, but the lung
tissue levels of IL-13 were still elevated.23 The level
of IL-13 mRNA in the lung tissue was not meas-
ured in our study. However, the role of IL-13 in
the pathology of repeated C. pneumoniae lung in-
fection cannot be ruled out and needs further
evaluation.
Airway remodeling is a summary term that
describes structural changes in the airway in
chronic asthma.30 C. pneumoniae lung infection
has not been explored for its ability to cause
these structural changes. By morphometric analy-
sis in our study, the thickness of the subepithelial
basement membrane of the airways increased 1.6-
fold in the infected mice in comparison with the
control mice. In addition, increased IL-4 mRNA
expression correlated positively with the increased
thickness of the subepithelial basement membrane
in infected mice.
In conclusion, we believe that we demon-
strated for the first time that chronic and repeated
C. pneumoniae respiratory infection induced Th2
immune response with increased IL-4 mRNA 
expression, and caused airway remodeling, with
increased thickness of the subepithelial basement
membrane in mice. These findings support spec-
ulation from epidemiologic studies that chronic
C. pneumoniae infection plays some role in the
initiation of intrinsic asthma. Further studies are
required, such as using IL-4 knockout mice and
analysis of cytokine expression in lung tissue of
infected mice, to clarify the causal relationship be-
tween IL-4 gene expression and increased thick-
ness of the subepithelial basement membrane in
chronic C. pneumoniae-infected mice.
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